EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study

Fernando Sabino Marques Monteiro iD, Antonio Machado Alencar Junior, Karine Martins da Trindade, Taiane Francieli Rebelatto, Fernando C Maluf, Antonia A Gazzola, Pablo M Barrios, Joaquim Bellmunt, Rafaela Gomes de Jesus, Gyl Eanes Barros Silva, Antonio Augusto Lima Teixeira Junior, Philippe E Spiess und 1 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Fernando Sabino Marques Monteiro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Penile Neoplasms, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Medicine Inc, Latin American Cooperative Oncology Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Penile squamous cell carcinoma (PSCC) is a rare malignancy. However, in developing countries the incidence rate is higher. The understanding of molecular alterations is essential for evaluating possible targets for more effective systemic therapies.

Methods

We retrospectively collected clinical data of metastatic PSCC (mPSCC) patients who had received at least one prior systemic treatment from 3 Brazilian hospitals. Tumor samples were evaluated using the next-generation sequencing (NGS) Foundation One DX and immunohistochemistry (IHC). The objective was to identify and describe somatic genomic alterations known to be functional or pathogenic and their association with survival outcomes.

Results

Twenty-three patients were identified, 22 and 18 patients had tumor samples analyzed by IHC and NGS, respectively. PD-L1 expression (CPS ≥ 1%) was positive in 14 patients (63.6%). Regarding the genomic alterations, 16 patients (88.9%) had some clinically relevant genomic alterations. TP53, TERT, CDKN2A, PIK3CA, NOTCH1, and CDKN2B loss were identified in 66.7%, 50%, 50%, 33.3%, 27.8%, and 22.2% of the patients, respectively. No MSI or TMB high (≥10 mutations/MB) cases were identified. NOTCH1 mutation was identified only in HPV-negative patients and it was associated with worse OS (yes: 5.5 vs no: 12.8 months, P = .049) and progression-free survival (yes: 5.5 vs no: 11.7 months, P = .032).

Conclusion

This study demonstrated that molecular alterations in mPSCC from developing countries are similar to those from developed countries. Predictive biomarkers for immunotherapy response such as TMB high or MSI were not identified. Specific gene mutations may identify patients with worse prognoses and open new avenues for therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penile NeoplasmsCarcinoma, Squamous CellBiomarkers, TumorHumansMaleMiddle AgedAgedRetrospective StudiesDeveloping CountriesBrazilAdultPrognosisTranslational Research, BiomedicalNeoplasm MetastasisMutation

Stichwörter der Autor:innen

genomic profilemetastatic diseasemolecular alterationspenile carcinoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
  • Hospital Sírio Libanês, Oncology and Hematology Department, Brasilia, Brazil.
  • Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), School of Medicine, Porto Alegre, Brazil.
  • Hospital Universitário da Universidade Federal do Maranhão, Oncology Department, São Luis, Brazil.
  • Instituto de Ensino e Pesquisa do Ceará, Fortaleza, Brazil.
  • Hospital Israelita Albert Einstein, Oncology and Hematology Department, São Paulo, Brazil.

ORCID-Profile: Fernando Sabino Marques Monteiro

Förderung

  • Foundation Medicine Inc
  • Latin American Cooperative Oncology Group

Zitieren

APA

Monteiro, F. S. M., Alencar Junior, A. M., da Trindade, K. M., Rebelatto, T. F., Maluf, F. C., Gazzola, A. A., Barrios, P. M., Bellmunt, J., de Jesus, R. G., Silva, G. E. B., Teixeira Junior, A. A. L., Spiess, P. E., & Fay, A. P. (2025). Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study. The Oncologist. https://doi.org/10.1093/oncolo/oyae220

Vancouver

Monteiro FSM, Alencar Junior AM, da Trindade KM, Rebelatto TF, Maluf FC, Gazzola AA, et al. Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study. The Oncologist. 2025. doi:10.1093/oncolo/oyae220

BibTeX
@article{Monteiro2025,
  author = {Monteiro, Fernando Sabino Marques and Alencar Junior, Antonio Machado and da Trindade, Karine Martins and Rebelatto, Taiane Francieli and Maluf, Fernando C and Gazzola, Antonia A and Barrios, Pablo M and Bellmunt, Joaquim and de Jesus, Rafaela Gomes and Silva, Gyl Eanes Barros and Teixeira Junior, Antonio Augusto Lima and Spiess, Philippe E and Fay, Andre P},
  title = {Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae220}
}
Kostenlos starten →